Novo Nordisk Healthcare AG
Novo Nordisk Rare Disease is focused on generating scientific and technological breakthroughs for people living with a rare disease via the discovery and development of integrated therapeutic solutions and novel indications of established medicines in rare and ultra-rare blood, endocrine and renal disorders. Formerly known as Novo Nordisk Biopharm, the franchise was renamed in 2022 to highlight the Company’s strategic direction and new areas of focus.
Brands: https://events.jspargo.com/ASH20/CUSTOM/novonordiskmedicalbanner.jpg